{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:35Z","timestamp":1787169575186,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.4103\/ijo.ijo_3054_21","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T07:53:23Z","timestamp":1648454003000},"page":"1299-1300","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Commentary: Managing treatment-resistant polypoidal choroidal vasculopathy \u2013 Evolving concepts"],"prefix":"10.4103","volume":"70","author":[{"given":"Divya","family":"Agarwal","sequence":"first","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Kumar","sequence":"additional","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kumar","sequence":"additional","affiliation":[{"name":"Medical Director, AK Institute of Ophthalmology, Safdarjung Enclave, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"B1-20240828","article-title":"Polypoidal choroidal vasculopathy: A comprehensive clinical update","volume":"11","author":"Kumar","year":"2019","journal-title":"Ther Adv Ophthalmol"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/IAE.0b013e3181a3b7d9","article-title":"Differences in macular morphology between polypoidal choroidal vasculopathy and exudative age-related macular degeneration detected by optical coherence tomography","volume":"29","author":"Ozawa","year":"2009","journal-title":"Retina"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: A randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: The EVEREST II randomized clinical trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.oret.2019.04.018","article-title":"Anti-vascular endothelial growth factor resistance in exudative macular degeneration and polypoidal choroidal vasculopathy","volume":"3","author":"Kokame","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ajoc.2018.01.031","article-title":"Management of recalcitrant polypoidal choroidal vasculopathy by feeder vessel laser photocoagulation","volume":"9","author":"Sheth","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B7-20240828","article-title":"Dexamethasone implant improves anatomic response to anti-VEGF therapy in treatment-resistant polypoidal choroidal vasculopathy","author":"Mallikarjun","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B8-20240828","article-title":"Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK","author":"Ogura","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4103\/ijo.IJO_2513_21","article-title":"Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes \u2013A multicenter retrospective study","volume":"70","author":"Chakraborty","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1038\/s41598-021-86014-7","article-title":"Short-term outcomes of intravitreal brolucizumab for treatment-na\u00efve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy","volume":"11","author":"Matsumoto","year":"2021","journal-title":"Sci Rep"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_3054_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:09:59Z","timestamp":1787166599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_3054_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_3054_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}